| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.013 | 0.8 |